Viewing Study NCT03787992


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2025-12-26 @ 8:35 AM
Study NCT ID: NCT03787992
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-11
First Post: 2018-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAG)
Sponsor: Allist Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module